Rucaparib is a potent, oral, small-molecule inhibitor of poly(ADP-ribose) polymerase (PARP) enzymes (including PARP1, PARP2, and PARP3) that exhibits activity against tumor cells with defects in DNA repair [1–5]. This evidence concerns the gene PARP1 and neoplasm.